Chicago protesters demanding access to FDA-approved Alzheimer's drugs

Singapore News News

Chicago protesters demanding access to FDA-approved Alzheimer's drugs
Singapore Latest News,Singapore Headlines
  • 📰 ABC7Chicago
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

The Alzheimer's Association said every day without access to FDA-approved drugs, approximately 2,000 people reach a stage of the disease where they are no longer eligible for treatment.

Copyright © 2023 WLS-TV. All Rights Reserved.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ABC7Chicago /  🏆 284. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alzheimer's May Be Next Frontier for Drugs Like OzempicAlzheimer's May Be Next Frontier for Drugs Like OzempicDiabetes drugs that also promote weight loss, such as Novo Nordisk’s Ozempic, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimers disease.
Read more »

FDA raises concerns about over-the-counter birth control pillFDA raises concerns about over-the-counter birth control pillU.S. regulators will vote this week on whether the contraceptive Opill should be made widely available without a prescription.
Read more »

FDA Recalls 500,000 COVID Test Kits Due to BacteriaFDA Recalls 500,000 COVID Test Kits Due to Bacteria🚨RECALL ALERT🚨: As many as half a million at-home COVID tests are being recalled due to potential bacterial contamination.
Read more »

Eyenovia's Mydcombi Gets FDA Nod for Pupil DilationEyenovia's Mydcombi Gets FDA Nod for Pupil DilationThe FDA has approved Mydcombi for the dilation of pupils during diagnostic procedures.
Read more »

Optimism for New AD Biomarkers and TreatmentsOptimism for New AD Biomarkers and TreatmentsIM2023: Emerging biomarkers and treatments offer more options to diagnose and manage Alzheimers disease and related dementias, but high costs and potentially serious complications mean using them with caution.
Read more »



Render Time: 2025-04-08 06:20:17